公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease | Song L.; He Y.; Ou J.; Zhao Y.; Li R.; Cheng J.; CHIN-HSIEN LIN ; Ho M.S. | Cell Reports | 52 | 48 | |
2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 38 | 41 | |
2020 | Corrigendum to: “Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma” [J Hepatol (2020) 121-129] (Journal of Hepatology (2020) 121-129 (S016882782030163X), (10.1016/j.jhep.2020.03.005)) | Kim N.; Cheng J.; Jung I.; JA-DER LIANG ; Shih Y.L.; Huang W.-Y.; Kimura T.; Lee V.H.F.; Zeng Z.C.; Zhenggan R.; Kay C.S.; Heo S.J.; Won J.Y.; Seong J. | Journal of Hepatology | 3 | 0 | |
2017 | Effects of Self-Assembled Monolayer Modification of Nickel Oxide Nanoparticles Layer on the Performance and Application of Inverted Perovskite Solar Cells | Wang Q.; Chueh C.-C.; Zhao T.; Cheng J.; Eslamian M.; Choy W.C.H.; Jen A.K.-Y.; CHU-CHEN CHUEH | ChemSusChem | 165 | ||
2018 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012 | Mehra R.; Seiwert T.Y.; Gupta S.; Weiss J.; Gluck I.; Eder J.P.; Burtness B.; Tahara M.; Keam B.; Kang H.; Muro K.; Geva R.; Chung H.C.; CHIA-CHI LIN ; Aurora-Garg D.; Ray A.; Pathiraja K.; Cheng J.; Chow L.Q.M.; Haddad R. | British Journal of Cancer | 303 | 256 | |
2019 | Genetic analysis of PODXL gene in patients with familial and young-onset Parkinson's disease in a Taiwanese population | Chen S.-J.; RUEY-MEEI WU ; Ho C.-H.; Cheng J.; Lin H.-Y.; CHIN-HSIEN LIN | Neurobiology of Aging | 1 | 1 | |
2010 | Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia breast cancer consortium | Long J.; Cai Q.; Shu X.-O.; Qu S.; Li C.; Zheng Y.; Gu K.; Wang W.; Xiang Y.-B.; Cheng J.; Chen K.; Zhang L.; Zheng H.; Shen C.-Y.; CHIUN-SHENG HUANG ; Hou M.-F.; Shen H.; Hu Z.; Wang F.; Deming S.L.; Kelley M.C.; Shrubsole M.J.; Khoo U.S.; Chan K.Y.K.; Chan S.Y.; Haiman C.A.; Henderson B.E.; le Marchand L.; Iwasaki M.; Kasuga Y.; Tsugane S.; Matsuo K.; Tajima K.; Iwata H.; Huang B.; Shi J.; Li G.; Wen W.; Gao Y.-T.; Lu W.; Zheng W. | PLoS Genetics | 102 | 92 | |
2001 | Long-term clinical outcome of spontaneous carotid cavernous sinus fistulae supplied by dural branches of the internal carotid artery | HON-MAN LIU ; Wang Y.; YA-FANG CHEN ; Cheng J.; Yip P.; YONG-KWANG TU | Neuroradiology | 48 | 36 | |
2009 | A Nationwide Population-Based Cohort Study Shows Reduced Hospitalization for Peptic Ulcer Disease Associated With H pylori Eradication and Proton Pump Inhibitor Use | Wu C.; Wu C.; MING-SHIANG WU ; Wang C.; Cheng J.; Kuo K.N.; Lin J. | Clinical Gastroenterology and Hepatology | 52 | 50 | |
2009 | Patterns of managing chronic hepatitis B treatment-related drug resistance: A survey of physicians in Mainland China, South Korea, Taiwan, and Thailand | Chainuvati S.; Cheng J.; Hou J.L.; Hsu C.W.; Jia J.D.; Komolmit P.; Kwon S.Y.; Lee C.H.; Li H.; Li Y.; CHUN-JEN LIU ; Neo B.L.; Peng C.Y.; Tanwandee T.; Wongcharatrawee S.; Wu J.C.; Yu M.L.; Zhang X.X. | Hepatology International | 9 | 8 | |
2018 | Pembrolizumab for the treatment of advanced salivary gland carcinoma | Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. | American Journal of Clinical Oncology: Cancer Clinical Trials | 148 | 119 | |
2014 | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Roberts K.G.; Li Y.; Payne-Turner D.; Harvey R.C.; YUNG-LI YANG ; Pei D.; McCastlain K.; Ding L.; Lu C.; Song G.; Ma J.; Becksfort J.; Rusch M.; Chen S.-C.; Easton J.; Cheng J.; Boggs K.; Santiago-Morales N.; Iacobucci I.; Fulton R.S.; Wen J.; Valentine M.; Cheng C.; Paugh S.W.; Devidas M.; Chen I-M.; Reshmi S.; Smith A.; Hedlund E.; Gupta P.; Nagahawatte P.; Wu G.; Chen X.; Yergeau D.; Vadodaria B.; Mulder H.; Winick N.J.; Larsen E.C.; Carroll W.L.; Heerema N.A.; Carroll A.J.; Grayson G.; Tasian S.K.; Moore A.S.; Keller F.; Frei-Jones M.; Whitlock J.A.; Raetz E.A.; White D.L.; Hughes T.P.; Guidry Auvil J.M.; Smith M.A.; Marcucci G.; Bloomfield C.D.; Mr?zek K.; Kohlschmidt J.; Stock W.; Kornblau S.M.; Konopleva M.; Paietta E.; Pui C.-H.; Jeha S.; Relling M.V.; Evans W.E.; Gerhard D.S.; Gastier-Foster J.M.; Mardis E.; Wilson R.K.; Loh M.L.; Downing J.R.; Hunger S.P.; Willman C.L.; Zhang J.; Mullighan C.G. | New England Journal of Medicine | 1048 | 933 | |
2010 | Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? | Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO ; Han K.-H.; Piratvisuth T. | Antiviral Therapy | 9 | 9 |